21Shares Injective Staking ETP (Ticker: NL:AINJ) offers investors a unique opportunity to gain exposure to the dynamic world of decentralized finance through the performance of Injective (INJ), a prominent player in the blockchain ecosystem. This exchange-traded product is specifically tailored for those interested in the Pair_Long INJ, Short USD category, which strategically focuses on capitalizing on the growth potential of INJ while simultaneously hedging against USD fluctuations.
As part of its niche investment strategy, AINJ leverages price data from CCData, a trusted source, to accurately reflect the value of the underlying asset in USD terms. This ensures that investors benefit from a transparent and reliable valuation mechanism, making it an attractive option for those looking to diversify their portfolio with innovative blockchain-based assets. The 21Shares Injective Staking ETP not only opens the door to the burgeoning world of Injective but also provides a sophisticated tool for managing currency exposure, appealing to both seasoned investors and newcomers eager to explore the potential of decentralized financial markets.
21Shares Injective Staking ETP (AINJ) Fund Flow Chart
21Shares Injective Staking ETP (AINJ) 1 year Net Flows: $132K
AINJ ETF FAQ
What was NL:AINJ’s price range in the past 12 months?
NL:AINJ lowest ETF price was $6.90 and its highest was $34.32 in the past 12 months.
What is the AUM of NL:AINJ?
As of Jul 16, 2025 The AUM of NL:AINJ is 2.17M.
Is NL:AINJ overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does NL:AINJ pay dividends?
NL:AINJ does not currently pay dividends.
How many shares outstanding does NL:AINJ have?
Currently, no data Available
Which hedge fund is a major shareholder of NL:AINJ?
Currently, no hedge funds are holding shares in NL:AINJ